gaining weight after stopping tirzepatide Prevent Regain Weight Regain After Tirzepatide: What

Key findings from this phase 2 obesity trial included: Mean weight reduction of up to approximately 24.2% at the highest dose (12 mg) after 48 weeks Dose-dependent reductions in body weight across all active treatment arms Significant reductions in waist circumference, blood pressure, and lipid parameters Improvements in fasting glucose and insulin resistance markers A separate phase 2 trial in adults with type 2 diabetes (published in 2023) demonstrated meaningful HbA1c reductions alongside substantial weight loss, suggesting potential dual utility in both obesity and glycaemic management

Additionally, it has been determined that Ipamorelin has the ability to boost the production of IGF-1, or Insulin-like Growth Factor 1

23, Robert Wood Johnson Foundation (2012)

Upgrade to Deluxe Hydrafacial for $225 during booking

Before starting tirzepatide, inform your healthcare provider about all medications and supplements you are taking to ensure safe and effective treatment